Sun Pharmaceuticals | SUNP - Interest Expense On Debt


Sun Pharmaceuticals reported INR859M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Aspen Pharmacare ZAR 631.5M 301.5M Jun/2024
Bharat Petroleum INR 6.27B 305.5M Jun/2026
Cipla INR 167.4M 2.9M Sep/2026
Dr.Reddys Laboratories INR 1.26B 198M Jun/2026
Jiangsu Hengrui CNY 254.59M 253.85M Sep/2025
Sh Fosun Pharma CNY 321.25M 2M Sep/2025
Sun Pharmaceuticals INR 859M 139.6M Mar/2026
UPL INR 8.19B 170M Sep/2026